A new study has linked Covid mRNA shots to a rare autoimmune disease that started to surge in 2021.
Scientists analyzed soaring cases that emerged in Yorkshire, England.
According to the peer-reviewed study, published in the renowned Lancet journal, a rare autoimmune disease surged in Yorkshire after the rollout of the Covid injections.
The number of cases peaked in 2021 and continued to surge through 2022.
Anti-MDA5 dermatomyositis is an inflammatory condition characterized by muscle weakness, skin rashes, and rapidly progressive lung disease.
The autoimmune disease is very rare.
In 2019, two people in Yorkshire, with a population of 3.6 million, tested positive for the disease.
In 2020, the number of positive cases increased to nine.
The highest number of new cases, 35, was reported in 2021, followed by a decrease to 16 new cases in 2022.
The recent increase in autoimmune cases may be linked to interactions between the COVID-19 virus and vaccine RNA, according to Dr. Dennis McGonagle.
McGonagle is a clinical professor of medicine at the University of Leeds.
He is also the senior author of the study.
In addition to the Lancet study, several case studies have documented new cases of anti-MDA5 following COVID-19 vaccination.